- Sampo reported a net income of €180 million, surpassing the estimated €143.8 million.
- Underwriting profit for Sampo was reported at €361 million.
- The company’s pretax profit was €219 million, exceeding the estimated €212 million.
- If pretax profit was €187 million, it fell short of the estimated €210.5 million.
- Hastings had a pretax profit of €52 million.
- There was a pretax loss of €29 million in the holding category.
- Earnings per share amounted to €0.31, above the estimated €0.28.
- Analyst ratings include 11 buys, 9 holds, and 3 sells for Sampo.
A look at Sampo Oyj Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have provided a comprehensive outlook for Sampo Oyj based on their Smart Scores. With a balanced score of 3 for Value, Dividend, and Growth, Sampo Oyj appears to be positioned steadily in terms of these key financial metrics. The company’s ability to withstand market shocks is rated at 4 for Resilience, suggesting a strong foundation for long-term stability. Furthermore, a score of 4 for Momentum indicates positive market sentiment and potential for growth in the near future.
Sampo Oyj, operating as an insurance brokerage firm offering various insurance products globally, seems to have a solid overall outlook according to the Smartkarma Smart Scores. The company’s balanced performance across different factors such as value, dividend, growth, resilience, and momentum indicates a potential for sustained growth and stability in the long run. Investors may find Sampo Oyj an attractive option considering its consistent performance across these dimensions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
